Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24


Blood Levels of Monoamine Precursors and Smoking in Patients with Schizophrenia.

Mathai AJ, Kanwar J, Okusaga O, Fuchs D, Lowry CA, Peng X, Giegling I, Hartmann AM, Konte B, Friedl M, Gragnoli C, Reeves GM, Groer MW, Rosenthal RN, Rujescu D, Postolache TT.

Front Public Health. 2016 Aug 30;4:182. doi: 10.3389/fpubh.2016.00182. eCollection 2016.


Revisiting the 'self-medication' hypothesis in light of the new data linking low striatal dopamine to comorbid addictive behavior.

Awad AG, Voruganti LL.

Ther Adv Psychopharmacol. 2015 Jun;5(3):172-8. doi: 10.1177/2045125315583820. Review.


[Risk factors for treatment adherence in patients with schizophrenia: case-control study].

Aarab C, Elghazouani F, Aalouane R, Rammouz I.

Pan Afr Med J. 2015 Mar 20;20:273. doi: 10.11604/pamj.2015.20.273.3380. eCollection 2015. French. No abstract available.


Sex-specific brain deficits in auditory processing in an animal model of cocaine-related schizophrenic disorders.

Broderick PA, Rosenbaum T.

Brain Sci. 2013 Apr 10;3(2):504-20. doi: 10.3390/brainsci3020504.


Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure.

Salo R, Fassbender C, Iosif AM, Ursu S, Leamon MH, Carter C.

Psychiatry Res. 2013 Dec 15;210(2):529-35. doi: 10.1016/j.psychres.2013.06.030. Epub 2013 Jul 26.


Neurologic manifestations of chronic methamphetamine abuse.

Rusyniak DE.

Psychiatr Clin North Am. 2013 Jun;36(2):261-75. doi: 10.1016/j.psc.2013.02.005. Epub 2013 Apr 11. Review.


Variants in the 15q25 gene cluster are associated with risk for schizophrenia and bipolar disorder.

Jackson KJ, Fanous AH, Chen J, Kendler KS, Chen X.

Psychiatr Genet. 2013 Feb;23(1):20-8. doi: 10.1097/YPG.0b013e32835bd5f1.


Patterns of Tobacco Consumption among Indian Men with Schizophrenia Compared to Their Male Siblings.

Vatss S, Mehar H, Bhatia T, Richard J, Gur RC, Gur RE, Nimgaonkar VL, Deshpande SN.

Psychiatry Investig. 2012 Sep;9(3):245-51. Epub 2012 Sep 6.


A novel SNP in COMT is associated with alcohol dependence but not opiate or nicotine dependence: a case control study.

Voisey J, Swagell CD, Hughes IP, Lawford BR, Young RM, Morris CP.

Behav Brain Funct. 2011 Dec 31;7:51. doi: 10.1186/1744-9081-7-51.


Neurologic manifestations of chronic methamphetamine abuse.

Rusyniak DE.

Neurol Clin. 2011 Aug;29(3):641-55. doi: 10.1016/j.ncl.2011.05.004. Epub 2011 Jun 24. Review.


Demographic and clinical correlates of substance abuse comorbidity in schizophrenia.

Aich TK, Sinha VK, Khess CR, Singh S.

Indian J Psychiatry. 2004 Apr;46(2):135-9.


Auditory steady state response in bipolar disorder: relation to clinical state, cognitive performance, medication status, and substance disorders.

Rass O, Krishnan G, Brenner CA, Hetrick WP, Merrill CC, Shekhar A, O'Donnell BF.

Bipolar Disord. 2010 Dec;12(8):793-803. doi: 10.1111/j.1399-5618.2010.00871.x.


GABAergic modulation of the 40 Hz auditory steady-state response in a rat model of schizophrenia.

Vohs JL, Chambers RA, Krishnan GP, O'Donnell BF, Berg S, Morzorati SL.

Int J Neuropsychopharmacol. 2010 May;13(4):487-97. doi: 10.1017/S1461145709990307. Epub 2009 Jul 23.


Novel research translates to clinical cases of schizophrenic and cocaine psychosis.

Nunes JV, Broderick PA.

Neuropsychiatr Dis Treat. 2007 Aug;3(4):475-85.


Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia.

Smith MJ, Barch DM, Wolf TJ, Mamah D, Csernansky JG.

Schizophr Res. 2008 Dec;106(2-3):294-9. doi: 10.1016/j.schres.2008.07.015. Epub 2008 Sep 5.


Substance abuse and schizophrenia: pharmacotherapeutic intervention.

Green AI, Noordsy DL, Brunette MF, O'Keefe C.

J Subst Abuse Treat. 2008 Jan;34(1):61-71. Epub 2007 Jun 15. Review.


Substance abuse in patients with schizophrenia.

Winklbaur B, Ebner N, Sachs G, Thau K, Fischer G.

Dialogues Clin Neurosci. 2006;8(1):37-43. Review.

Supplemental Content

Support Center